WhatsApp Image 2026-07-30 at 2.57. 16 PM (2). jpeg
Off-Plan
12
AED1.600.000
Geschätzte Zahlung AED 6,6 Tsd./Monat
Finanzierung prüfen
Azalea, Masaar, Tilal City, Sharjah
2 Schlafzimmer
3 Bäder
183 m²

Reihenhaus in Tilal City,Masaar,Azalea, 2 schlafzimmer, 1600000 AED - 16878754

An excellent opportunity to own a 2-bedroom townhouse in Azalea, Masaar, Sharjah, available at an attractive distress deal price. This property is ideal for buyers looking for a below-market opportunity in a premium residential community with a nature-inspired lifestyle.
Property Details:
  • 2-bedroom townhouse
  • Located in Azalea, Masaar, Sharjah
  • Attractive distress deal price
  • 50% cash payment required immediately
  • Remaining payment subject to the agreed transaction terms
  • Suitable for end-users and property investors
  • Located in a green, family-friendly community
Community Features:
Masaar offers a unique lifestyle surrounded by greenery, landscaped spaces, and walking and cycling trails. Residents can enjoy a peaceful residential environment with convenient access to community facilities and essential amenities.
Why Choose This Property?
This is an excellent opportunity for serious buyers seeking a distress deal in Azalea. With 50% cash required now, buyers should be prepared with the necessary funds to proceed with the transaction. The attractive pricing makes this property worth considering for both personal use and long-term investment.
Contact us today for the asking price, payment breakdown, and further details or to arrange a viewing.

Objektinformationen

  • TypReihenhaus
  • ZweckVerkauf
  • Referenznr.Bayut - 103668-a7gddM
  • FertigstellungOff-Plan
  • Hinzugefügt am16. Oktober 2026
  • ÜbergabedatumQ4 2025

Validierte Informationen

Validated Check Mark Icon

Hypothek

Berechne und sieh dir die monatliche Hypothek für diese Reihenhaus an

Merkmale / Ausstattung

Parkplätze: 2
Haushälterzimmer
Schwimmbad
Zentralklimaanlage
+ 17 weitere Ausstattungen

Projektinformationen

Validated Check Mark Icon

Trends & Indizes

Regulatorische Informationen

Für Sie empfohlen